November 25, 2024 - 22:01

IceCure Medical Ltd. has announced that its next-generation multiprobe cryoablation technology has received a Notice of Allowance from Japan's Patent Office. This significant development marks a key milestone for the company's innovative approach to minimally invasive medical procedures.
The multiprobe cryoablation technology is designed to enhance the effectiveness and efficiency of cryoablation treatments, which are used to destroy abnormal tissues through extreme cold. This advancement is expected to provide physicians with improved tools for treating various medical conditions, potentially leading to better patient outcomes.
The approval from Japan's Patent Office underscores the technological advancements that IceCure is bringing to the field of cryoablation, positioning the company for growth in the competitive medical technology market.
December 19, 2025 - 08:21
MIT Senior Innovates with Community-Focused TechnologiesJulia Schneider, a senior at MIT, is making waves by harnessing her technical skills to address pressing issues within her community. Her journey began at the Biomimetic Robotics Lab, where she...
December 18, 2025 - 20:47
Channel Partners Conference & Expo 2026: Shaping the Future of TechnologyLAS VEGAS, December 18, 2025—As the technology channel gears up for a transformative era, the Channel Partners Conference & Expo alongside the MSP Summit 2026 is set to take place at The Venetian...
December 18, 2025 - 11:04
Angleton ISD Implements AI Technology for Enhanced School SafetyWhen it comes to school safety, every second matters, especially since gun violence is now the leading cause of death for children and teens. In a groundbreaking move, Angleton Independent School...
December 17, 2025 - 22:21
Is Now the Right Time to Invest in Credo Technology After a 28% Drop?A recent decline of 28% in Credo Technology`s stock has raised eyebrows among investors. Despite this sharp fall, it`s important to note that the company`s stock has skyrocketed over 800% over the...